HCC1806 and B. MX-1 human triple negative breast cancer sorted by
relevance

Admin01.10.2021

HCC1806 and B. MX-1 human triple negative breast cancer

509
Admin13.09.2021

HCC1806 and B. MX-1 human triple negative breast cancer

306
Admin18.09.2021

HCC1806 and B. MX-1 human triple negative breast cancer

3507
Admin10.08.2021

HCC1806 and B. MX-1 human triple negative breast cancer

8502
Admin26.09.2021

Treatment of HCC1806 and MX-1 human TNBC tumors with the

7306
Admin31.07.2021

In Vivo Delivery of miR-193a-3p Inhibits Growth of Triple

2707
Admin01.10.2021

In Vivo Delivery of miR-193a-3p Inhibits Growth of Triple

19010
Admin07.09.2021

Modulation of Estrogen α and Progesterone Receptors in

6200
Admin29.09.2021

In Vivo Delivery of miR-193a-3p Inhibits Growth of Triple

81010
Admin04.08.2021

In Vivo Delivery of miR-193a-3p Inhibits Growth of Triple

Admin08.09.2021

In Vivo Delivery of miR-193a-3p Inhibits Growth of Triple

Admin22.07.2021

Real-time PCR analysis of ERα, PR, and HER2 receptor

Admin04.10.2021

| (A-D) G47-mIL12 efficiently infects and kills murine

3507
Admin25.07.2021

ASCT2/SLC1A5 controls glutamine uptake and tumour growth

19010
Admin31.08.2021

Sensitizing Triple-Negative Breast Cancer to PI3K

1801
Admin19.08.2021

(PDF) Novel Model for Basaloid Triple-negative Breast

3607
Admin07.09.2021

Triple negative breast cancers express receptors for LHRH

4109
Admin22.09.2021

Aging | Pyrrolo [3,4- b ]-quinolin-9-amine compound FZU

Admin05.08.2021

In vivo combination activity of eribulin with platinum

3404
Admin21.07.2021

SLX4IP and telomere dynamics dictate breast cancer

1004
Admin30.09.2021

Multiple Molecular Subtypes of Triple-Negative Breast

6109